LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News REGULATION FLASH M impact Sep 21, 2026, 05:10 AM UTC

Thailand considering oil tax cut, finance minister says

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

CL

Related stories

Cohance Lifesciences reports FDA Form 483 for Andhra unit Cohance Lifesciences says the U.S. FDA issued Form 483 with five observations for its Jaggaiahpet unit in Andhra Pradesh. M impact | REGULATION | Sep 21, 2026, 06:17 AM UTC Trump extends $100,000 H-1B employer fee; Nifty IT slips US President Donald Trump extended by a year a $100,000 fee on employers for bringing in foreign workers on H-1B visas, the White House said, with the Nifty IT index falling 0.7% o M impact | REGULATION | Sep 21, 2026, 06:11 AM UTC Indonesia grants Bayan Resources 15-20 mln tons of additional coal mining quota Indonesia has issued an additional mining quota of around 15 to 20 million metric tons to three units of coal miner Bayan Resources, energy ministry official Tri Winarno said on Mo M impact | REGULATION | Sep 21, 2026, 06:08 AM UTC AstraZeneca's Klygefa drug recommended for EU approval by CHMP The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended Klygefa (gefurulimab) for approval in the EU as an add-on therapy for a M impact | REGULATION | Sep 21, 2026, 06:07 AM UTC AstraZeneca's Enhertu recommended for EU approval for early breast cancer AstraZeneca and Daiichi Sankyo's Enhertu has been recommended for approval in the EU as a treatment for adult patients with resected HER2-positive breast cancer who have residual d M impact | REGULATION | Sep 21, 2026, 06:03 AM UTC BONESUPPORT submits complete CERAMENT V De Novo additional data to FDA BONESUPPORT Holding AB said it has submitted the complete additional data package for the CERAMENT V De Novo submission to the U.S. FDA. M impact | REGULATION | Sep 21, 2026, 06:01 AM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.